Aminoacids and derivatives
Amino acids are compounds with a structure based on an amino group (-NH₂) and a carboxyl group (-COOH), both attached to a central carbon atom. This structure makes them essential for the synthesis of proteins and other biomolecules. Their derivatives can have regulatory properties over metabolic processes and biological systems, with applications in nutrition, health, and regenerative medicine.
At CymitQuimica, we offer a wide range of amino acids and their derivatives, ideal for research and the formulation of bioactive products.
Found 12270 products of "Aminoacids and derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
1-(3-Methyoxypropyl)-piperazine
CAS:Formula:C8H18N2OPurity:97.0%Color and Shape:LiquidMolecular weight:158.245PYRROLO[3,4-B]-1,4-OXAZINE-6(2H)-CARBOXYLIC ACID, HEXAHYDRO-4-(PHENYLMETHYL)-, 1,1-DIMETHYLETHYL ESTER
CAS:Purity:95.0%Molecular weight:318.41699218753-(4-Chlorophenyl)glutaric Acid
CAS:<p>Applications 3-(4-Chlorophenyl)glutaric Acid (cas# 35271-74-0) is a compound useful in organic synthesis. Baclofen Impurity 1<br></p>Formula:C11H11ClO4Color and Shape:NeatMolecular weight:242.668-Benzyl-3,8-diazabicyclo[3.2.1]octane dihydrochloride
CAS:Purity:95.0%Molecular weight:275.2200012207031Ref: 10-F232401
1gTo inquire5gTo inquire10gTo inquire25gTo inquire100mgTo inquire250mgTo inquire500mgTo inquire3-(4-Chlorophenyl)-4-hydroxybutyric Acid Sodium Salt
CAS:Controlled Product<p>Applications A metabolite of Baclofen (c).<br>References Ault, B., et al.: Eur. J. Pharmacol., 71, 357 (1981),<br></p>Formula:C10H10ClNaO3Color and Shape:NeatMolecular weight:236.63Desacetyl Desmethyl Lacosamide
CAS:Controlled Product<p>Applications Desacetyl Desmethyl Lacosamide is an impurity of Lacosamide (L098500) which is a potent anticonvulsant.<br>References Lees, G., et al.: Brain Res., 612, 190 (1993), Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006), Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007),<br></p>Formula:C10H14N2O2Color and Shape:NeatMolecular weight:194.233-(4-Chlorophenyl)glutaric Anhydride
CAS:Controlled Product<p>Stability Moisture Sensitive<br>Applications 3-(4-Chlorophenyl)glutaric Anhydride (cas# 53911-68-5) is a compound useful in organic synthesis.<br></p>Formula:C11H9ClO3Color and Shape:Off-WhiteMolecular weight:224.64Lacosamide
CAS:Controlled Product<p>Applications Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lees, G., et al.: Brain Res., 612, 190 (1993), Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006), Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007),<br></p>Formula:C13H18N2O3Color and Shape:Off-WhiteMolecular weight:250.29(R)-2-Amino-N-benzyl-3-methoxypropionamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications (R)-2-Amino-N-benzyl-3-methoxypropionamide is an impurity of Lacosamide which is a potent anticonvulsant.<br>References Letiran, A., et al.: J. Med. Chem., 45, 4762 (2002); Wadavrao, S., et al.: Synthesis, 45, 3383 (2013)<br></p>Formula:C11H16N2O2Color and Shape:Colourless To Light YellowMolecular weight:208.269-BENZYL 2-TERT-BUTYL 2,6,9-TRIAZASPIRO[4.5]DECANE-2,9-DICARBOXYLATE
CAS:Purity:95.0%Molecular weight:375.468994140625cis-Tranexamic Acid
CAS:Controlled ProductFormula:C8H15NO2Color and Shape:White To Light BeigeMolecular weight:157.218-Bromo-1,8a-dihydro-imidazo[1,2-a]pyridine-2-carboxylic acid amide
Purity:95.0%Molecular weight:242.0760040283203N-Descarboxymethyl-N-carboxyethyl Lacosamide (Impurity)
CAS:Controlled Product<p>Applications N-Descarboxymethyl-N-carboxyethyl Lacosamide is an impurity of Lacosamide (L098500), an anticonvulsant drug that enhances sodium channel slow inactivation, and is used to treat patients with epilepsy.<br>References Doty, P., et al.: Neurotherapeutics, 4, 145 (2007); Perucca, E., et al.: Nat. Rev. Drug Discov., 7, 973 (2008); Sake, J., et al.: CNS Drugs, 24, 1055 (2010)<br></p>Formula:C14H20N2O3Color and Shape:NeatMolecular weight:264.321-(5-Chloro-2-methoxy-phenyl)-piperazine hydrochloride
CAS:Purity:98.0%Color and Shape:SolidMolecular weight:263.1600036621094N-(Phenylacetyl-d5)glycine
CAS:Controlled Product<p>Applications A labelled metabolite of carboxylic acid.<br>References Bardsley, W., et al.: Biochem. J., 122, 557 (1971), Kim, J., et al.: Biosci. Biotechnol. Biochem., 69, 1331 (2005), Kopka, J., et al.: J. Biotechnol., 124, 312 (2006),<br></p>Formula:C10D5H6NO3Color and Shape:WhiteMolecular weight:198.23
![PYRROLO[3,4-B]-1,4-OXAZINE-6(2H)-CARBOXYLIC ACID, HEXAHYDRO-4-(PHENYLMETHYL)-, 1,1-DIMETHYLETHYL E…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF504047.webp&w=3840&q=75)
![8-Benzyl-3,8-diazabicyclo[3.2.1]octane dihydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF232401.webp&w=3840&q=75)
![9-BENZYL 2-TERT-BUTYL 2,6,9-TRIAZASPIRO[4.5]DECANE-2,9-DICARBOXYLATE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF502143.webp&w=3840&q=75)
![8-Bromo-1,8a-dihydro-imidazo[1,2-a]pyridine-2-carboxylic acid amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF545696.webp&w=3840&q=75)
